NEW YORK STATE COMMON RETIREMENT FUND - RHYTHM PHARMACEUTICALS INC ownership

RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 91 filers reported holding RHYTHM PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
NEW YORK STATE COMMON RETIREMENT FUND ownership history of RHYTHM PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$473
+42.9%
20,641
+2.7%
0.00%
Q2 2023$331
+1642.1%
20,100
+1775.0%
0.00%
Q1 2023$19
-38.7%
1,0720.0%0.00%
Q4 2022$31
-99.9%
1,0720.0%0.00%
Q3 2022$26,000
+2500.0%
1,072
+241.4%
0.00%
Q2 2022$1,000
-99.7%
314
-99.0%
0.00%
Q1 2022$352,000
+15.4%
30,582
+0.0%
0.00%
Q4 2021$305,000
-33.6%
30,576
-13.0%
0.00%
Q3 2021$459,000
-41.5%
35,165
-12.3%
0.00%
-100.0%
Q2 2021$785,000
+5.4%
40,107
+14.6%
0.00%0.0%
Q1 2021$745,000
-19.2%
35,005
+12.9%
0.00%0.0%
Q4 2020$922,000
+27.7%
31,005
-6.9%
0.00%0.0%
Q3 2020$722,000
-2.8%
33,3050.0%0.00%0.0%
Q2 2020$743,000
+66.6%
33,305
+13.6%
0.00%0.0%
Q1 2020$446,000
-17.4%
29,305
+24.7%
0.00%0.0%
Q4 2019$540,000
+6.5%
23,5050.0%0.00%0.0%
Q3 2019$507,000
-1.9%
23,5050.0%0.00%0.0%
Q2 2019$517,000
+10.2%
23,505
+37.4%
0.00%0.0%
Q1 2019$469,000
+2.0%
17,1050.0%0.00%0.0%
Q4 2018$460,000
+15.9%
17,105
+25.7%
0.00%
Q3 2018$397,000
-6.6%
13,6050.0%0.00%
-100.0%
Q2 2018$425,000
+160.7%
13,605
+65.8%
0.00%
Q1 2018$163,000
-22.0%
8,205
+14.0%
0.00%
Q4 2017$209,0007,2000.00%
Other shareholders
RHYTHM PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
MPM ASSET MANAGEMENT LLC 909,258$10,475,0003.58%
NEA Management Company, LLC 4,912,306$56,590,0001.64%
RA Capital Management 4,871,067$56,115,0001.22%
Pinz Capital Management, LP 148,475$1,710,0001.07%
Samsara BioCapital, LLC 345,293$3,978,0001.00%
Bell & Brown Wealth Advisors, LLC 117,400$1,352,0000.61%
Rock Springs Capital Management LP 1,237,026$14,251,0000.36%
ACT CAPITAL MANAGEMENT, LLC 27,500$317,0000.34%
Endurant Capital Management LP 105,792$1,219,0000.32%
Baker Brothers Advisors 4,125,062$47,521,0000.27%
View complete list of RHYTHM PHARMACEUTICALS INC shareholders